Remicade® (Infliximab) Immunosuppressant

Infliximab belongs to a class of biologic medications known as tissue necrosis factor alpha (TNF-α)-blockers. Excess amounts of TNF-α causes the immune system to attack healthy cells in the target area such as gastrointestinal (GI) tract or joints, resulting in inflammation. Infliximab binds to TNF-α, blocking its action to help improve symptoms.

Nufactor carries REMICADE® (Infliximab):

FDA-Approved Indication
Product: REMICADE® (Infliximab)
Manufacturer: Janssen Biotech, Inc.
FDA-Approved Indication: Rheumatoid Arthritis,
Crohn's Disease,
Pediatric Crohn's Disease,
Ankylosing Spondylitis,
Psoriatic Arthritis,
Plaque Psoriasis,
Ulcerative Colitis,
Pediatric Ulcerative Colitis
Click here for a REMICADE (Infliximab) order form

Contact Nufactor

At Nufactor, we are committed to providing our patients the education, support and resources necessary to complete your IVIG treatment successfully and with the desired outcomes. Please contact us with any further questions.